DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Anastasilakis AD, Papapoulos SE, Polyzos SA. et al.
Zoledronate for the prevention of bone loss in women discontinuing denosumab
treatment. A prospective 2-year clinical trial.
J Bone Miner Res 2019;
34: 2220-2228
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.